Aramark director granted 24.471 dividend units

Aramark director Karen Marie King accrued additional dividend-equivalent share units tied to deferred stock, increasing her direct holdings.

Rhea-AI Filing Summary

Aramark (symbol: ARMK) is the issuer of record for a Form 4 filing submitted to the SEC. King Karen Marie reported acquisition or exercise transactions in this Form 4 filing.

Aramark (ARMK) reported that director Karen Marie King received an award of 24.471 shares of Common Stock equivalents on September 9, 2026. These represent dividend equivalent rights that accrued on her deferred stock units in connection with Aramark’s quarterly dividend and vest on the same schedules as the underlying awards. Following this award, she holds 42,827.279 common-share equivalents directly. No Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

Grant/Award: 24.471 shares

Grant/Award 1 txn

Insider King Karen Marie

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	24.471	$0.00	$0.00

Holdings After Transaction: Common Stock — 42,827.279 shares (Direct)

Footnotes (1)

1. F1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Key Figures

Shares acquired: 24.471 shares Holdings after transaction: 42,827.279 shares Transaction price per share: $0.00 per share +1 more

4 metrics

Shares acquired 24.471 shares Dividend equivalent rights awarded to Karen Marie King on September 9, 2026

Holdings after transaction 42,827.279 shares Direct common-share equivalents held by Karen Marie King after the award

Transaction price per share $0.00 per share Reported price for the dividend equivalent rights award on September 9, 2026

Transaction type Grant/award acquisition Form 4 code A for non-derivative common stock equivalents

Key Terms

dividend equivalent rights, deferred stock units, quarterly dividend

3 terms

dividend equivalent rights financial

"Represents dividend equivalent rights in connection with the Issuer's quarterly dividend"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

deferred stock units financial

"accrued to the reporting person on deferred stock units held by the reporting person"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

quarterly dividend financial

"in connection with the Issuer's quarterly dividend and accrued to the reporting person"

A quarterly dividend is a payment a company gives to its shareholders four times a year, usually as a share of its profits. It's like getting a small bonus every few months for owning the company's stock, which can provide a steady income. Investors watch these payments to see how well a company is doing and whether it’s a good investment.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Aramark (ARMK) report for Karen Marie King?

Aramark reported that director Karen Marie King acquired 24.471 common-share equivalents on September 9, 2026 as dividend equivalent rights accruing on her deferred stock units in connection with the company’s quarterly dividend.

How many Aramark (ARMK) shares does Karen Marie King hold after this transaction?

After the September 9, 2026 award, Karen Marie King directly holds 42,827.279 Aramark common-share equivalents, reflecting her updated position including the newly accrued dividend equivalent rights.

What is the nature of the 24.471 Aramark (ARMK) shares reported on this Form 4?

The 24.471 Aramark common-share equivalents are dividend equivalent rights that accrued on Karen Marie King’s deferred stock units in connection with Aramark’s quarterly dividend and vest on the same schedules as the underlying awards.

Did Karen Marie King buy Aramark (ARMK) shares on the open market?

No. The Form 4 describes a grant/award acquisition of 24.471 dividend equivalent rights tied to deferred stock units, with a reported price of $0.00 per share, rather than an open-market purchase.

Was the Aramark (ARMK) insider transaction under a Rule 10b5-1 plan?

No. The filing’s Rule 10b5-1 checkbox is not marked as affirming a plan, and no footnote states that the September 9, 2026 award to Karen Marie King was made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 04:16 PM Accepted by SEC EDGAR 09/10/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

King Karen Marie

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PENNSYLVANIA 19103

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/09/2026		A		24.471(1)	A	$0	42,827.279	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)